Drug-drug Interactions
/ Pharmacokinetics
Drug-drug
Interactions
with Antifungal Agents
-
10/12/0
Pharmacokinetic
Interaction between
Darunavir/ritonavir and Efavirenz in Healthy HIV Negative Volunteers
- 8/28/07
Bioequivalence
of Pilot 100 mg Tablet Formulations of Ritonavir to the Marketed Soft Gel Capsule
- 3/09/07
Pharmacokinetics
and Dosing of MK-0518 in Healthy Volunteers
10/10/06 New
Data on MK-0518 Drug Interactions
10/10/06 Pharmacokinetics
and Safety of New NRTI Fosalvudine Tidoxil
- 8/25/06
Drug
Interactions between Brecanavir and other HIV Protease Inhibitors - 8/15/06
Pharmacokinetic
and Safety Evaluation of High-dose Combinations of Fosamprenavir and Ritonavir - 3/21/06
Combination
of Boosted Tipranavir and Experimental PI TMC 125 Is Not Recommended - 2/28/06
Acid-reducing
Agents Do Not Alter the Pharmacokinetics of Lopinavir/Ritonavir Tablet - 2/21/06
Large
International Trial Finds Continuous Anti-HIV Therapy Is Greatly Superior to Treatment
Interruptions: The SMART Study - 1/20/06
Study
of Possible Drug-drug Interactions between Tenofovir and Nevirapine and
Efavirenz in HIV patients - 1/17//06
The Pharmacokinetic Interaction Between
the Entry Inhibitor Aplaviroc (APL, 873140) and Efavirenz in Healthy Adults.
K Adkinson and others. -
12/18/05
Rising
Multiple-Dose Assessment of Vicriviroc – Similar Safety, Tolerability, and Pharmacokinetics
in Uninfected and HIV-Infected Adults. A Sansone and others. -
12/18/05
Absence of Pharmacokinetic (PK) Drug
Interaction Between Aplaviroc (APL, 873140) and Tenofovir Disoproxil Fumarate
(TDF). I Song and others. -
12/18/05
Co-administration of Fosamprenavir/Ritonavir
Overcomes the Effect of Efavirenz Induction on Aplaviroc (APL; 873140) Pharmacokinetics,
K Adkinson and others. -
12/18/05
Pharmacokinetic Interaction Between
Rifabutin (RFB) and Fosamprenavir (FPV)/ Ritonavir (RTV) in Healthy Subjects,
Y Chon and others. -
12/18/05
Effect
of Omeprazole on the Pharmacokinetics of Saquinavir 500 mg Formulation
with Ritonavir - 12/05/05
|
|
